2) Intratumoral Chemotherapy
瘤内化疗
1.
Experimental Observation of Intratumoral Chemotherapy of Chitosan-cisplatin Microspheres in C6 Glioma Rats;
目的:观察壳聚糖-顺铂缓释微球对C6胶质瘤瘤内化疗的疗效。
4) interstitial chemotherapy
间质内化疗
1.
Effect of photodynamic therapy combined with interstitial chemotherapy for gliomas;
光动力学疗法与间质内化疗联合治疗脑胶质瘤的临床研究
2.
Objective To explore the influential factors of stability to BCNU-PLGA sustained release microspheres used for interstitial chemotherapy to brain glioma.
目的探讨用于脑胶质瘤间质内化疗的BCNU-PLGA缓释微球稳定性的影响因素。
3.
Objective To investigate the sensitivity of combined chemotherapy of CBP, Vm-26, MTX and NIM against glioma, and to explore the inhibition of them to glioma so as to offer scientific basis for clinic interstitial chemotherapy.
目的观察卡铂(CBP)、威猛(Vm-26)、甲氨喋呤(MTX)及尼莫地平(NIM)联合应用对脑胶质瘤的抑制作用,探讨脑间质内联合用药与胶质瘤细胞敏感性的关系,为临床脑胶质瘤间质内化疗提供有效的化疗依据。
5) Intratumoral chemotherapy
肿瘤内化疗
6) Intraperitoneal chemotherapy
腹腔内化疗
1.
Assessment on efficacy of adjuvant intraperitoneal chemotherapy on advanced gastric carcinoma after radical treatment;
进展期胃癌根治性术后腹腔内化疗的疗效评价(英文)
2.
Intraperitoneal chemotherapy for malignant ascites of gastric cancer based on the results of in vitro drug sensitivity test of anticancer agents;
药物敏感试验指导胃癌合并恶性腹水的腹腔内化疗
3.
Assessment on the efficacy of intraperitoneal chemotherapy on progressive gastric cancer after radical treatment;
进展期胃癌根治性术后腹腔内化疗的疗效评价
补充资料：卵巢癌动脉内化疗
卵巢癌动脉内化疗
此化疗系指将抗癌药物注入卵巢癌的营养动脉，使抗癌药物在组织内浓度增高，提高其抗肿瘤效果，减少全身分布，减轻不良反应。方法是在手术时，将导管插入肿瘤的营养血管，或暴露腹壁下动脉或股动脉逆行插入导管，随后注入化疗药物。更常用的是经皮穿刺插入导管，常用为Seldinger,Cobra和Headhuter等导管，通过股动脉在X线直视下插入导管至所需灌注的动脉，如需反复灌注，可将导管末端连接在埋藏在皮下的药物泵，以后可经皮肤反复穿刺给药。在动脉化疗前，应先进行肿瘤区的血管造影，也肯定导管是否进入主供血管。动脉内灌注时，卵巢癌局部药物浓度较血液中浓度高，而血液中反跳浓度则出现较晚。最常用的药物为阿霉素、顺铂、卡铂、足叶乙甙等。有时可配合全身化疗同时应用，所用的药物可和全身化疗一样。动脉内灌注常可同时进行供血动脉栓塞。这样可控制手术时出血和使周围组织在手术时易于分离。动脉内化疗、灌注动脉选择常分为3种：1.亚选择性：导管插入腹主动脉第3腰椎水平。2.选择性：导管插入髂内动脉。3.超选择性：导管插入卵巢动脉或肿瘤供血动脉。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条